Dr. Reddy's Laboratories Limited (RDY)

Dr. Reddy's Laboratories Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Year Ending	Current	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	13,009	12,215	9,475	9,268	10,201	6,697
Market Cap Growth	28.92%	28.92%	2.23%	-9.15%	52.32%	-0.33%
Enterprise Value	12,276	11,478	8,887	9,130	10,143	6,649
PE Ratio	19.53	18.28	17.28	29.97	43.44	25.90
PS Ratio	3.88	3.65	3.17	3.29	3.95	2.89
PB Ratio	3.88	3.63	3.37	3.71	4.33	3.26
P/FCF Ratio	57.14	53.41	19.43	74.90	28.75	20.10
P/OCF Ratio	23.98	22.41	13.23	25.13	20.97	16.92
EV/Sales Ratio	3.67	3.43	2.97	3.25	3.92	2.87
EV/EBITDA Ratio	11.62	10.82	9.81	15.43	18.53	15.92
EV/EBIT Ratio	13.97	13.00	11.82	20.92	27.19	26.37
EV/FCF Ratio	53.92	50.19	18.22	73.78	28.58	19.95
Debt / Equity Ratio	0.07	0.07	0.06	0.18	0.18	0.14
Debt / EBITDA Ratio	0.23	0.23	0.18	0.75	0.75	0.70
Debt / FCF Ratio	1.05	1.05	0.34	3.59	1.16	0.88
Quick Ratio	1.68	1.68	1.56	1.18	1.01	1.07
Current Ratio	2.58	2.58	2.38	1.93	1.78	1.79
Asset Turnover	0.79	0.79	0.80	0.77	0.76	0.76
Interest Coverage	43.00	43.00	43.27	34.71	28.23	19.34
Return on Equity (ROE)	21.80%	21.80%	21.40%	13.00%	10.50%	13.20%
Return on Assets (ROA)	15.70%	15.70%	14.70%	8.40%	6.90%	8.50%
Return on Capital (ROIC)	17.46%	17.46%	17.45%	9.59%	7.79%	9.77%
Earnings Yield	5.14%	5.47%	5.79%	3.34%	2.30%	3.86%
FCF Yield	1.75%	1.87%	5.15%	1.34%	3.48%	4.98%
Dividend Yield	1.23%	1.30%	1.40%	1.20%	0.50%	0.70%
Payout Ratio	24.02%	24.30%	23.40%	36.70%	23.30%	17.10%
Buyback Yield / Dilution	-0.06%	-0.06%	-0.07%	-0.08%	-0.06%	-0.09%
Total Shareholder Return	1.17%	1.24%	1.33%	1.12%	0.44%	0.61%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).